2024

• Rastogi, P., O'Shaughnessy, J., Martin, M., Boyle, F., Cortes, J., Rugo, H., Goetz, M., Hamilton, E., Huang, C., Senkus, E., et al (2024). Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of Clinical Oncology, 42(9), 987-993. [More Information]
• Laidsaar-Powell, R., Schofield, P., Boyle, F., Yates, P., White, K., Sundaresan, P., Varadarajan, S., Juraskova, I., Giunta, S., Butow, P., Turner, S., Costa, D., Kay, J., et al (2024). An online intervention to improve oncology health professional self-efficacy in communicating with carers: Hybrid effectiveness-implementation evaluation of the eTRIO program. Patient Education and Counseling, 124, 108251. [More Information]
• Gnant, M., Abdullah, K., Boyle, F., Huang, C., Bickford, K., Neunie, S., Noble, A., Nunn, A., Sproat, C., Harbeck, N., et al (2024). Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis. JMIR Formative Research, 8. [More Information]
• Laidsaar-Powell, R., Giunta, S., Butow, P., Keast, R., Koczwara, B., Kay, J., Jefford, M., Turner, S., Saunders, C., Schofield, P., Boyle, F., White, K., Butt, Z., Bonnaudet, M., Juraskova, I., et al (2024). Development of Web-Based Education Modules to Improve Carer Engagement in Cancer Care: Design and User Experience Evaluation of the e-Triadic Oncology (eTRIO) Modules for Clinicians, Patients, and Carers. JMIR Medical Education, 10, e50118. [More Information]
• Medeiros, P., Flenady, V., Andrews, C., Forbes, M., Boyle, F., Loughnan, S., Meredith, N., Gordon, A. (2024). Evaluation of an online education program for healthcare professionals on best practice management of perinatal deaths: IMPROVE eLearning. Australian and New Zealand Journal of Obstetrics and Gynaecology, 64(1), 63-71. [More Information]
• Andrews, C., Boyle, F., Pade, A., Middleton, P., Ellwood, D., Gordon, A., Davies-Tuck, M., Homer, C., Griffin, A., Nicholl, M., et al (2024). Experiences of antenatal care practices to reduce stillbirth: surveys of women and healthcare professionals pre-post implementation of the Safer Baby Bundle. BMC Pregnancy and Childbirth, 24(1). [More Information]
• Mackie, G., Boyle, F., Lewis, S., Smith, A. (2024). Finding my tribe: a qualitative interview study of how people living with metastatic breast cancer perceive support groups. Journal of Cancer Survivorship. [More Information]

2023

• Toi, M., Boyle, F., Im, Y., Reinisch, M., Molthrop, D., Jiang, Z., Wei, R., Sapunar, F., Grimes, B., Nabinger, S., et al (2023). Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1. The Oncologist, 28(1), e77-e81. [More Information]
• Hutchings, E., Butcher, B., Butow, P., Boyle, F. (2023). Attitudes of Australian breast cancer patients toward the secondary use of administrative and clinical trial data. Asia-Pacific Journal of Clinical Oncology, 19(2), e12-e26. [More Information]
• Pal, A., Smith, B., Allan, C., Karikios, D., Boyle, F. (2023). Improving Access to Cancer Clinical Trials for Patients from Culturally and Linguistically Diverse Backgrounds in Australia: A Survey of Clinical and Research Professionals. JCO Oncology Practice, 19(11), 1039-1047. [More Information]
• Dempsey, K., Boyle, F., King, M., Spillane, A., Mathieu, E., Brennan, M., Snook, K., Hoffman, J., Campbell, I., Scarlet, J., et al (2023). Patient-reported health-related quality of life outcomes following mastectomy for breast cancer, with immediate, delayed or no breast reconstruction: Four-year follow-up from a prospective cohort study. Breast, 71, 122-131. [More Information]
• Lewis, S., Newton, G., Kenny, K., Boyle, F. (2023). The incurable self: Negotiating social bonds and dis/connection with metastatic breast cancer. Sociology of Health & Illness. [More Information]
• McCaffrey, N., Cheah, S., Luckett, T., Phillips, J., Agar, M., Davidson, P., Boyle, F., Shaw, T., Currow, D., Lovell, M. (2023). Treatment patterns and out-of-hospital healthcare resource utilisation by patients with advanced cancer living with pain: An analysis from the Stop Cancer PAIN trial. PloS One, 18(2 February). [More Information]

2022

• Rugo, H., O'Shaughnessy, J., Boyle, F., Toi, M., Broom, R., Blancas, I., Gumus, M., Yamashita, T., Im, Y., Rastogi, P., et al (2022). Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study. Annals of Oncology, 33(6), 616-627. [More Information]
• Lim, E., Boyle, F., Okera, M., Loi, S., Goksu, S., van Hal, G., Chapman, S., Gable, J., Chen, Y., Price, G., et al (2022). An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer. Breast Cancer Research and Treatment, 195(3), 275-287. [More Information]
• Warrilow, K., Gordon, A., Andrews, C., Boyle, F., Wojcieszek, A., Stuart Butler, D., Ellwood, D., Middleton, P., Cronin, R., Flenady, V. (2022). Australian women's perceptions and practice of sleep position in late pregnancy: An online survey. Women and Birth, 35(2), e111-e117. [More Information]
• Safi, N., Anazodo, A., Dickinson, J., Boyle, F., Wang, A., Li, Z., Sullivan, E. (2022). Clinical Decision Making in the Management of Breast Cancer Diagnosed During Pregnancy: A Review and Case Series Analysis. Journal of Adolescent and Young Adult Oncology, 11(3), 245-251. [More Information]
• Mizrahi, D., Goldstein, D., Kiernan, M., Robinson, L., Pitiyarachchi, O., McCullough, S., Mendoza-Jones, P., Grimison, P., Boyle, F., Park, S. (2022). Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer, 30(7), 5965-5974. [More Information]
• Khoo, P., Groeneveld, T., Boyle, F., O'Neill, S., Forster, B., Watson, S. (2022). Dry eye signs and symptoms in patients on aromatase inhibitor therapy. Eye, 36(4), 766-772. [More Information]
• Lovell, M., Phillips, J., Luckett, T., Lam, L., Boyle, F., Davidson, P., Cheah, S., McCaffrey, N., Currow, D., Shaw, T., Clarke, S., Lee, J., Clark, K., et al (2022). Effect of Cancer Pain Guideline Implementation on Pain Outcomes Among Adult Outpatients With Cancer-Related Pain: A Stepped Wedge Cluster Randomized Trial. JAMA Network Open, 5(2), e220060-1-e220060-12. [More Information]
• Dempsey, K., Saw, R., Bartula, I., Lo, S., Lawn, C., Pennington, T., Spillane, A., Boyle, F., Dong, S., Dieng, M., Morton, R., et al (2022). Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): Protocol for a prospective, longitudinal, mixed-methods pilot study. BMJ Open, 12(12). [More Information]
• Beatty, L., Kemp, E., Butow, P., Girgis, A., Hulbert-Williams, N., Kaambwa, B., Schofield, P., Turner, J., Woodman, R., Boyle, F., et al (2022). Finding My Way-Advanced: can a web-based psychosocial intervention improve the mental quality of life for women with metastatic breast cancer vs attention-control? Study protocol of a randomised controlled trial. BMC Cancer, 22(1). [More Information]
• Loughnan, S., Boyle, F., Ellwood, D., Crocker, S., Lancaster, A., Astell, C., Dean, J., Horey, D., Callander, E., Jackson, C., Shand, A., et al (2022). Living with Loss: study protocol for a randomized controlled trial evaluating an internet-based perinatal bereavement program for parents following stillbirth and neonatal death. Trials, 23(1). [More Information]
• Batty, K., Taylor, A., Bernard, E., Diakos, C., Clarke, S., Guminski, A., Baron-Hay, S., Boyle, F., Pavlakis, N., Chan, D. (2022). Metastatic primary breast neuroendocrine neoplasms: a case series. Internal Medicine Journal. [More Information]
• Flenady, V., Gardener, G., Ellwood, D., Coory, M., Weller, M., Warrilow, K., Middleton, P., Wojcieszek, A., Groom, K., Boyle, F., Andrews, C., et al (2022). My Baby's Movements: A Stepped-Wedge Cluster-Randomised Controlled Trial of a Fetal Movement Awareness Intervention to Reduce Stillbirths. Obstetrical and Gynecological Survey, 77(3), 137-139. [More Information]
• Flenady, V., Gardener, G., Ellwood, D., Coory, M., Weller, M., Warrilow, K., Middleton, P., Wojcieszek, A., Groom, K., Boyle, F., Gordon, A., et al (2022). My Baby’s Movements: a stepped-wedge cluster-randomised controlled trial of a fetal movement awareness intervention to reduce stillbirths. BJOG, 129(1), 29-41. [More Information]
• Loi, S., Karapetis, C., McCarthy, N., Oakman, C., Redfern, A., White, M., Khasraw, M., Doval, D., Gore, V., Alam, M., et al (2022). Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer for whom letrozole therapy is deemed appropriate: An expanded access study in Australia and India. Asia-Pacific Journal of Clinical Oncology, 18(6), 560-569. [More Information]
• Boyle, F., Horey, D., Dean, J., Lohan, A., Middleton, P., Flenady, V. (2022). Perinatal bereavement care during COVID-19 in Australian maternity settings. Journal of Perinatal Medicine, 50(6), 822-831. [More Information]
• Sullivan, E., Safi, N., Li, Z., Remond, M., Chen, T., Javid, N., Dickinson, J., Ives, A., Hammarberg, K., Anazodo, A., Boyle, F., et al (2022). Perinatal outcomes of women with gestational breast cancer in Australia and New Zealand: A prospective population-based study. Birth, 49(4), 763-773. [More Information]
• Meiser, B., Woodward, P., Gleeson, M., Kentwell, M., Mar Fan, H., Antill, Y., Butow, P., Boyle, F., Best, M., Taylor, N., Bell, K., et al (2022). Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients. Familial Cancer, 21(2), 157-166. [More Information]
• Smith, A., Boyle, F., Lewis, S. (2022). Potential inequities in availability of care from breast care nurses: a qualitative study reporting the experiences and perspectives of women with metastatic breast cancer in Australia. BMC Health Services Research, 22(1). [More Information]
• Wong, V., de Boer, R., Baron-Hay, S., Blum, R., Boyle, F., Chua, S., Clarke, K., Cuff, K., Green, M., Lim, E., et al (2022). Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer. Clinical Breast Cancer, 22(8), 792-800. [More Information]
• Dempsey, K., Mathieu, E., Brennan, M., Snook, K., Hoffman, J., Campbell, I., Scarlet, J., Flay, H., Wong, A., Boyle, F., King, M., Spillane, A. (2022). The role of breast reconstruction choice on body image patient-reported outcomes at four years post-mastectomy for breast cancer: A longitudinal prospective cohort study. Psycho-Oncology, 31(1), 54-61. [More Information]
• Maccora, J., Garland, S., Ftanou, M., Day, D., White, M., Lopez, V., Mortimer, D., Diggens, J., Phillips, A., Wallace, R., et al (2022). The sleep, cancer and rest (SleepCaRe) trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapy. Contemporary Clinical Trials, 120. [More Information]
• Lindeman, G., Fernando, T., Bowen, R., Jerzak, K., Song, X., Decker, T., Boyle, F., McCune, S., Armstrong, A., Shannon, C., et al (2022). VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results. Clinical Cancer Research, 28(15), 3256-3267. [More Information]

2021

• Hutchings, E., Loomes, M., Butow, P., Boyle, F. (2021). A systematic literature review of attitudes towards secondary use and sharing of health administrative and clinical trial data: a focus on consent. Systematic Reviews, 10(1), 1-44. [More Information]
• Oh, B., Van Der Saag, D., Morgia, M., Carroll, S., Boyle, F., Back, M., Lamoury, G. (2021). An Innovative Tai Chi and Qigong Telehealth Service in Supportive Cancer Care During the COVID-19 Pandemic and Beyond. American Journal of Lifestyle Medicine, 15(4), 475-477. [More Information]
• Oh, B., Boyle, F., Pavlakis, N., Clarke, S., Guminski, A., Eade, T., Lamoury, G., Carroll, S., Morgia, M., Kneebone, A., Hruby, G., Stevens, M., Molloy, M., Back, M., et al (2021). Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review. Frontiers in Oncology, 11, 706331. [More Information]
• Juraskova, I., Laidsaar-Powell, R., Keast, R., Schofield, P., Costa, D., Kay, J., Turner, S., Koczwara, B., Saunders, C., Jefford, M., Boyle, F., White, K., Morton, R., Butt, Z., Butow, P., et al (2021). eTRIO trial: study protocol of a randomised controlled trial of online education modules to facilitate effective family caregiver involvement in oncology. BMJ Open, 11, e043224. [More Information]
• Knight, A., Pollock, D., Boyle, F., Horey, D., Warland, J. (2021). Evidence available to guide care during labor and birth for women and their partners who know their baby will be stillborn: A scoping review protocol. JBI Evidence Synthesis, 19(8), 1984-1991. [More Information]
• Fallowfield, L., Boyle, F., Travado, L., Kiely, B., Jewell, P., Aubel, D., Cardoso, F. (2021). Gaps in Care and Support for Patients With Advanced Breast Cancer: A Report From the Advanced Breast Cancer Global Alliance. JCO Global Oncology, 7, 976-984. [More Information]
• Cameron, B., Webber, K., Li, H., Bennett, B., Boyle, F., de Souza, P., Wilcken, N., Lynch, J., Friedlander, M., Goldstein, D., et al (2021). Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study. Brain, Behavior, & Immunity - Health, 10.0. [More Information]
• Boyle, F., Horey, D., Siassakos, D., Burden, C., Bakhbakhi, D., Silver, R., Flenady, V. (2021). Parent engagement in perinatal mortality reviews: an online survey of clinicians from six high-income countries. BJOG, 128(4), 696-703. [More Information]
• Horey, D., Boyle, F., Cassidy, J., Cassidy, P., Erwich, J., Gold, K., Gross, M., Heazell, A., Leisher, S., Murphy, M., et al (2021). Parents’ experiences of care offered after stillbirth: An international online survey of high and middle-income countries. Birth, 48(3), 366-374. [More Information]
• Mueller, V., Wardley, A., Paplomata, E., Hamilton, E., Zelnak, A., Fehrenbacher, L., Jakobsen, E., Curtit, E., Boyle, F., Harder Brix, E., et al (2021). Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial). European Journal of Cancer, 153, 223-233. [More Information]
• Pal, A., Stapleton, S., Yap, C., Lai-Kwon, J., Daly, R., Magkos, D., Baikady, B., Minchom, A., Banerji, U., De Bono, J., Karikios, D., Boyle, F., et al (2021). Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT). BMJ Open, 11(9), e049217. [More Information]
• Oh, B., Boyle, F., Pavlakis, N., Clarke, S., Eade, T., Hruby, G., Lamoury, G., Carroll, S., Morgia, M., Kneebone, A., Stevens, M., Molloy, M., Kong, B., Back, M., et al (2021). The gut microbiome and cancer immunotherapy: Can we use the gut microbiome as a predictive biomarker for clinical response in cancer immunotherapy? Cancers, 13(19), 4824. [More Information]
• Oh, B., Eade, T., Lamoury, G., Carroll, S., Morgia, M., Kneebone, A., Hruby, G., Stevens, M., Boyle, F., Clarke, S., Molloy, M., Back, M., et al (2021). The gut microbiome and gastrointestinal toxicities in pelvic radiation therapy: A clinical review. Cancers, 13(10), 2353. [More Information]
• Lewis, S., Kenny, K., Broom, A., Kirby, E., Boyle, F. (2021). The social meanings of choice in living-with advanced breast cancer. Social Science and Medicine, 280, 1-8. [More Information]
• Moreno-Aspitia, A., Holmes, E., Jackisch, C., de Azambuja, E., Boyle, F., Hillman, D., Korde, L., Fumagalli, D., Izquierdo, M., McCullough, A., et al (2021). Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D). European Journal of Cancer, 148, 287-296. [More Information]
• Timmins, H., Li, T., Trinh, T., Kiernan, M., Harrison, M., Boyle, F., Friedlander, M., Goldstein, D., Park, S. (2021). Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response. The Oncologist, 26(5), 366-374. [More Information]

2020

• Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M., Andre, F., Barrios, C., Bergh, J., Bhattacharyya, G., Biganzoli, L., Kiely, B., et al (2020). 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Annals of Oncology, 31(12), 1623-1649. [More Information]
• Hutchings, E., Loomes, M., Butow, P., Boyle, F. (2020). A systematic literature review of health consumer attitudes towards secondary use and sharing of health administrative and clinical trial data: A focus on privacy, trust, and transparency. Systematic Reviews, 9(1), 1-41. [More Information]
• Hutchings, E., Loomes, M., Butow, P., Boyle, F. (2020). A systematic literature review of researchers' and healthcare professionals' attitudes towards the secondary use and sharing of health administrative and clinical trial data. Systematic Reviews, 9(1), 1-27. [More Information]
• Johnston, S., Harbeck, N., Hegg, R., Toi, M., Martin, M., Shao, Z., Zhang, Q., Rodriguez, J., Campone, M., Hamilton, E., et al (2020). Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR1, HER22, node-positive, high-risk, early breast cancer (monarchE). Journal of Clinical Oncology, 38(34), 3987-3998. [More Information]
• Rumbold, A., Yelland, J., Stuart Butler, D., Forbes, M., Due, C., Boyle, F., Middleton, P. (2020). Addressing stillbirth inequities in Australia: Steps towards a better future. Women and Birth, 33(6), 520-525. [More Information]
• Winstanley, J., White, E., Saw, R., Young, T., Burmeister, B., Nikolic, D., Busto-Cornide, I., Iglesias-Pena, N., Boyle, F. (2020). Development of the Melanoma Concerns Questionnaire (MCQ-28 refinement of the EORTC QLQ-MEL38 module. Psycho-Oncology, 29(2), 321-330. [More Information]
• Timmins, H., Li, T., Huynh, W., Kiernan, M., Baron-Hay, S., Boyle, F., Goldstein, D., Park, S. (2020). Electrophysiological and phenotypic profiles of taxane-induced neuropathy. Clinical Neurophysiology, 131(8), 1979-1985. [More Information]
• Andrews, C., Ellwood, D., Middleton, P., Gordon, A., Nicholl, M., Homer, C., Morris, J., Gardener, G., Coory, M., Davies-Tuck, M., Bauman, A., et al (2020). Implementation and evaluation of a quality improvement initiative to reduce late gestation stillbirths in Australia: Safer Baby Bundle study protocol. BMC Pregnancy and Childbirth, 20(1), 694. [More Information]
• Boyle, F., Allen, J., Rey-Conde, T., North, J. (2020). Learning from regret. British Journal of Surgery, 107(4), 422-431. [More Information]
• Lisy, K., Lai-Kwon, J., Ward, A., Sandhu, S., Kasparian, N., Winstanley, J., Boyle, F., Gyorki, D., Lacey, K., Bishop, J., et al (2020). Patient-reported outcomes in melanoma survivors at 1, 3 and 5 years post-diagnosis: a population-based cross-sectional study. Quality of Life Research, 29(8), 2021-2027. [More Information]
• Flenady, V., Middleton, P., Hooper, S., Morris, J., Gordon, A., Boyle, F., Homer, C., Henry, S., Brezler, L., Wojcieszek, A., et al (2020). Stillbirth in Australia 1: The road to now: Two decades of stillbirth research and advocacy in Australia. Women and Birth, 33(6), 506-513. [More Information]
• Boyle, F., Horey, D., Dean, J., Loughnan, S., Ludski, K., Mead, J., Homer, C., de Wilde, D., Morris, J., Flenady, V. (2020). Stillbirth in Australia 5: Making respectful care after stillbirth a reality: The quest for parent-centred care. Women and Birth, 33(6), 531-536. [More Information]
• Choummanivong, M., Karimi, S., Durham, J., Sychareun, V., Flenady, V., Horey, D., Boyle, F. (2020). Stillbirth in Lao PDR: a healthcare provider perspective. Global Health Action, 13(sup2). [More Information]
• Timmins, H., Li, T., Kiernan, M., Baron-Hay, S., Marx, G., Boyle, F., Goldstein, D., Park, S. (2020). Taxane-induced peripheral neuropathy: differences in patient report and objective assessment. Supportive Care in Cancer, 28(9), 4459-4466. [More Information]
• Jang, A., Brown, C., Lamoury, G., Morgia, M., Boyle, F., Marr, I., Clarke, S., Back, M., Oh, B. (2020). The Effects of Acupuncture on Cancer-Related Fatigue: Updated Systematic Review and Meta-Analysis. Integrative Cancer Therapies, 19. [More Information]
• Oh, B., Bae, K., Lamoury, G., Eade, T., Boyle, F., Corless, B., Clarke, S., Yeung, A., Rosenthal, D., Schapira, L., Back, M. (2020). The Effects of Tai Chi and Qigong on Immune Responses: A Systematic Review and Meta-Analysis. Medicines, 7(7), 39. [More Information]
• Shakespeare, C., Merriel, A., Bakhbakhi, D., Blencowe, H., Boyle, F., Flenady, V., Gold, K., Horey, D., Lynch, M., Mills, T., et al (2020). The RESPECT Study for consensus on global bereavement care after stillbirth. International Journal of Gynecology & Obstetrics, 149(2), 137-147. [More Information]
• Eakin, E., Reeves, M., Goode, A., Winkler, E., Vardy, J., Boyle, F., Haas, M., Hiller, J., Mishra, G., Jefford, M., Chapman, K., et al (2020). Translating research into practice: Outcomes from the Healthy Living after Cancer partnership project. BMC Cancer, 20(1), 963. [More Information]

2019

• Phillips, J., Heneka, N., Lovell, M., Lam, L., Davidson, P., Boyle, F., McCaffrey, N., Fielding, S., Shaw, T. (2019). A phase III wait-listed randomised controlled trial of novel targeted inter-professional clinical education intervention to improve cancer patients' reported pain outcomes (The Cancer Pain Assessment (CPAS) Trial): study protocol. Trials, 20(1), 1-12. [More Information]
• Lambertini, M., Campbell, C., Bines, J., Korde, L., Izquierdo, M., Fumagalli, D., Del Mastro, L., Ignatiadis, M., Pritchard, K., Boyle, F., et al (2019). Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients. Journal of the National Cancer Institute, 111(1), 86-94. [More Information]
• Rohde, G., Young, T., Winstanley, J., Arraras, J., Black, K., Boyle, F., Bredart, A., Costantini, A., Guo, J., Irarrazaval, M., et al (2019). Associations between sex, age and spiritual well-being scores on the EORTC QLQ-SWB32 for patients receiving palliative care for cancer: A further analysis of data from an international validation study. European Journal of Cancer Care, 28(6), 1-11. [More Information]
• Luckett, T., Davidson, P., Green, A., Marie, N., Birch, M., Stubbs, J., Phillips, J., Agar, M., Boyle, F., Lovell, M. (2019). Development of a cancer pain self-management resource to address patient, provider, and health system barriers to care. Palliative and Supportive Care, 17(4), 472-478. [More Information]
• Moore, H., Unger, J., Phillips, K., Boyle, F., Hitre, E., Moseley, A., Porter, D., Francis, P., Goldstein, L., Gomez, H., et al (2019). Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230. Journal of the National Cancer Institute, 111(2), 210-213. [More Information]
• Daly, L., Boyle, F., Gibbons, K., Le, H., Roberts, J., Flenady, V. (2019). Mobile applications providing guidance about decreased fetal movement: Review and content analysis. Women and Birth, 32(3), e289-e296. [More Information]
• Shakespeare, C., Merriel, A., Bakhbakhi, D., Baneszova, R., Barnard, K., Lynch, M., Storey, C., Blencowe, H., Boyle, F., Flenady, V., et al (2019). Parents’ and healthcare professionals’ experiences of care after stillbirth in low- and middle-income countries: a systematic review and meta-summary. BJOG, 126(1), 12-21. [More Information]
• Zdenkowski, N., Butow, P., Spillane, A., Douglas, C., Snook, K., Jones, M., Oldmeadow, C., Fewster, S., Beckmore, C., Boyle, F. (2019). Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer. The Breast, 46, 25-31. [More Information]
• Lee, C., Scott, C., Lindeman, G., Hamilton, A., Lieschke, E., Gibbs, E., Asher, R., Badger, H., Paterson, R., Macnab, L., et al (2019). Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer. British Journal of Cancer, 120(3), 279-285. [More Information]
• Tervonen, H., Chen, T., Lin, E., Boyle, F., Moylan, E., Della Fiorentina, S., Beith, J., Johnston, A., Currow, D. (2019). Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia. European Journal of Cancer Care, 28(5), 1-11. [More Information]
• Lovell, M., Birch, M., Luckett, T., Phillips, J., Davidson, P., Agar, M., Boyle, F. (2019). Screening and Audit as Service-Level Strategies to Support Implementation of Australian Guidelines for Cancer Pain Management in Adults: A Feasibility Study. Pain Management Nursing, 20(2), 113-117. [More Information]
• Huober, J., Holmes, E., Baselga, J., de Azambuja, E., Untch, M., Fumagalli, D., Sarp, S., Lang, I., Smith, I., Boyle, F., et al (2019). Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer. European Journal of Cancer, 118, 169-177. [More Information]
• Pinto, A., Adams, S., Ahring, K., Allen, H., Almeida, M., Garcia-Arenas, D., Arslan, N., Assoun, M., Atik Altınok, Y., Barrio-Carreras, D., et al (2019). Weaning practices in phenylketonuria vary between health professionals in Europe. Molecular Genetics and Metabolism Reports, 18, 39-44. [More Information]

2018

• Oh, B., Yeung, A., Klein, P., Larkey, L., Ee, C., Zaslawski, C., Knobf, M., Payne, P., Stener-Victorin, E., Lee, R., Pavlakis, N., Boyle, F., Clarke, S., Back, M., et al (2018). Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training Institutions. Medicines, 5(2), 51. [More Information]
• Shaw, J., O'Brien, J., Chua, S., De Boer, R., Dear, R., Murray, N., Boyle, F. (2018). Barriers and enablers to implementing scalp cooling in Australia: a qualitative study of health professionals' attitudes to and experience with scalp cooling. Supportive Care in Cancer, 26(1), 305-312. [More Information]
• Wojcieszek, A., Boyle, F., Belizán, J., Cassidy, J., Cassidy, P., Erwich, J., Farrales, L., Gross, M., Heazell, A., Leisher, S., et al (2018). Care in subsequent pregnancies following stillbirth: an international survey of parents. BJOG, 125(2), 193-201. [More Information]
• Pinto, A., Adams, S., Ahring, K., Allen, H., Almeida, M., Garcia-Arenas, D., Arslan, N., Assoun, M., Atik Altınok, Y., Barrio-Carreras, D., et al (2018). Early feeding practices in infants with phenylketonuria across Europe. Molecular Genetics and Metabolism Reports, 16, 82-89. [More Information]
• Lim, E., Beith, J., Boyle, F., de Boer, R., Hui, R., McCarthy, N., Redfern, A., Wade, T., Woodward, N. (2018). Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer. Asia-Pacific Journal of Clinical Oncology, 14(Suppl 4), 12-21. [More Information]
• Herrmann, A., Boyle, F., Butow, P., Hall, A., Zdenkowski, N. (2018). Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer. Health Science Reports, e213, 1-9. [More Information]
• Laidsaar-Powell, R., Butow, P., Boyle, F., Juraskova, I. (2018). Facilitating collaborative and effective family involvement in the cancer setting: Guidelines for clinicians (TRIO Guidelines-1). Patient Education and Counseling, 101(6), 970-982. [More Information]
• Hammarberg, K., Sullivan, E., Javid, N., Duncombe, G., Halliday, L., Boyle, F., Saunders, C., Ives, A., Dickinson, J., Fisher, J. (2018). Health care experiences among women diagnosed with gestational breast cancer. European Journal of Cancer Care, 27(2), 1-11. [More Information]
• Boyle, F., Beith, J., Burslem, K., de Boer, R., Hui, R., Lim, E., McCarthy, N., Redfern, A., Woodward, N. (2018). Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm. Asia-Pacific Journal of Clinical Oncology, 14(Suppl 4), 3-11. [More Information]
• Smith, K., Winstanley, J., Boyle, F., O’Reilly, A., White, M., Antill, Y. (2018). Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy. Supportive Care in Cancer, 26(2), 483-489. [More Information]
• Laidsaar-Powell, R., Butow, P., Boyle, F., Juraskova, I. (2018). Managing challenging interactions with family caregivers in the cancer setting: Guidelines for clinicians (TRIO Guidelines-2). Patient Education and Counseling, 101(6), 983-994. [More Information]
• Luckett, T., Phillips, J., Agar, M., Lam, L., Davidson, P., McCaffrey, N., Boyle, F., Shaw, T., Currow, D., Read, A., et al (2018). Protocol for a phase III pragmatic stepped wedge cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of screening and guidelines with, versus without, implementation strategies for improving pain in adults with cancer attending outpatient oncology and palliative care services: the Stop Cancer PAIN trial. BMC Health Services Research, 18(1), 1-13. [More Information]
• Zdenkowski, N., Butow, P., Spillane, A., Douglas, C., Snook, K., Jones, M., Oldmeadow, C., Fewster, S., Beckmore, C., Boyle, F. (2018). Single-Arm Longitudinal Study to Evaluate a Decision Aid for Women Offered Neoadjuvant Systemic Therapy for Operable Breast Cancer. Journal of the National Comprehensive Cancer Network, 16(4), 378-385. [More Information]
• Daly, L., Horey, D., Middleton, P., Boyle, F., Flenady, V. (2018). The effect of mobile app interventions on influencing healthy maternal behavior and improving perinatal health outcomes: Systematic review. JMIR mHealth and uHealth, 6(8). [More Information]
• Schirmann, A., Boyle, F., Horey, D., Siassakos, D., Ellwood, D., Rowlands, I., Flenady, V. (2018). Understanding mothers’ decision-making needs for autopsy consent after stillbirth: Framework analysis of a large survey. Birth, 45(3), 255-262. [More Information]

2017

• Franklin, A., Lovell, M., Boyle, F. (2017). A Case of Opioid Toxicity on Conversion From Extended-Release Oxycodone and Naloxone to Extended-Release Oxycodone in a Patient With Liver Dysfunction. Journal of Pain and Symptom Management, 53(2), e1-e2. [More Information]
• Shaw, J., Boyle, F. (2017). Chemotherapy induced alopecia and strategies to manage its impact. Cancer Forum, 41(1), 1-6. [More Information]
• Lopez, D., Kemp-Casey, A., Saunders, C., Roughead, E., Boyle, F., Bulsara, M., Preen, D. (2017). Clinical consultations and investigations before and after discontinuation of endocrine therapy in women with primary breast cancer. Public Health Research and Practice, 27(3), 1-7. [More Information]
• Lovell, M., Boyle, F. (2017). Communication strategies and skills for optimum pain control. In D. Kissane, B. Bultz, P. Butow, C. Bylund, S. Noble & S. Wilkinson (Eds.), Oxford Textbook of Communication in Oncology and Palliative Care (Second Edition), (pp. 244-248). Oxford: Oxford University Press. [More Information]
• Bray, V., Dhillon, H., Bell, M., Kabourakis, M., Fiero, M., Yip, D., Boyle, F., Price, M., Vardy, J. (2017). Evaluation of a Web-Based Cognitive Rehabilitation Program in Cancer Survivors Reporting Cognitive Symptoms After Chemotherapy. Journal of Clinical Oncology, 35(2), 217-225. [More Information]
• Lui, C., Boyle, F., Wysocki, A., Baker, P., D'Souza, A., Faint, S., Rey-Conde, T., North, J. (2017). How participation in surgical mortality audit impacts surgical practice. BMC Surgery, 17(1). [More Information]
• Martin, J., Julovi, S., Lin, Z., de Silva, H., Boyle, F., Baxter, R. (2017). Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade. Breast Cancer Research, 19(1), 1-14. [More Information]
• Kandula, T., Farrar, M., Kiernan, M., Krishnan, A., Goldstein, D., Horvath, L., Grimison, P., Boyle, F., Baron-Hay, S., Park, S. (2017). Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer. Clinical Neurophysiology, 128(7), 1166-1175. [More Information]
• McCrary, J., Goldstein, D., Boyle, F., Cox, K., Grimison, P., Kiernan, M., Krishnan, A., Lewis, C., Webber, K., Baron-Hay, S., Horvath, L., Park, S. (2017). Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey. Supportive Care in Cancer, 25(11), 3485-3493. [More Information]
• Ibiebele, I., Boyle, F., Horey, D., Lourie, R., Wilson, P., Coory, M., Flenady, V. (2017). Predictors of autopsy following stillbirth in Queensland, Australia: A population-based study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(1), 33-39. [More Information]
• Sandler, C., Goldstein, D., Horsfield, S., Bennett, B., Friedlander, M., Bastick, P., Lewis, C., Segelov, E., Boyle, F., Chin, M., et al (2017). Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue. Journal of Pain and Symptom Management, 54(1), 74-84. [More Information]
• Kemp-Casey, A., Roughead, E., Saunders, C., Boyle, F., Bulsara, M., Preen, D. (2017). Switching between endocrine therapies for primary breast cancer: Frequency and timing in Australian clinical practice. Asia-Pacific Journal of Clinical Oncology, 13(2), e161-e170. [More Information]
• Daly, L., Horey, D., Middleton, P., Boyle, F., Flenady, V. (2017). The effect of mobile application interventions on influencing healthy maternal behaviour and improving perinatal health outcomes: A systematic review protocol. Systematic Reviews, 6(1). [More Information]
• Vivat, B., Young, T., Winstanley, J., Arraras, J., Black, K., Boyle, F., Bredart, A., Costantini, A., Guo, J., Irarrazaval, M., et al (2017). The international phase 4 validation study of the EORTC QLQ-SWB32: A stand-alone measure of spiritual well-being for people receiving palliative care for cancer. European Journal of Cancer Care, 26(6), 1-19. [More Information]
• Eakin, E., Hayes, S., Reeves, M., Goode, A., Vardy, J., Boyle, F., Haas, M., Hiller, J., Mishra, G., Jefford, M., et al (2017). Translating Research into Community Practice: The Healthy Living after Cancer Partnership Project. Obesity, 25, S31-S31. [More Information]

2016

• Zdenkowski, N., Butow, P., Hutchings, E., Douglas, C., Coll, J., Boyle, F. (2016). A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study (ANZ1301 DOMINO). Journal of Medical Internet Research, 5(2), 1-11. [More Information]
• Zdenkowski, N., Butow, P., Mann, G., Fewster, S., Beckmore, C., Isaacs, R., Douglas, C., Boyle, F. (2016). A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer. Internal Medicine Journal, 46(6), 677-683. [More Information]
• Zdenkowski, N., Butow, P., Tesson, S., Boyle, F. (2016). A systematic review of decision aids for patients making a decision about treatment for early breast cancer. The Breast, 26, 31-45. [More Information]
• Piccart-Gebhart, M., Holmes, E., Baselga, J., De Azambuja, E., Dueck, A., Viale, G., Zujewski, J., Goldhirsch, A., Amour, A., Pritchard, K., Boyle, F., et al (2016). Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial. Journal of Clinical Oncology, 34(10), 1034-1042. [More Information]
• Phillips, K., Regan, M., Ribi, K., Francis, P., Puglisi, F., Bellet, M., Spazzapan, S., Karlsson, P., Budman, D., Zaman, K., Coates, A., Boyle, F., et al (2016). Adjuvant ovarian function suppression and cognitive function in women with breast cancer. British Journal of Cancer, 114(9), 956-964. [More Information]
• Kemp-Casey, A., Roughead, E., Saunders, C., Boyle, F., Lopez, D., Bulsara, M., Preen, D. (2016). Breast cancer recurrence following active treatment: Determining its incidence in the NSW population. Public Health Research and Practice, 26(1), 1-8. [More Information]
• Dong, S., Butow, P., Agar, M., Lovell, M., Boyle, F., Stockler, M., Forster, B., Jaure, A. (2016). Clinicians' Perspectives on Managing Symptom Clusters in Advanced Cancer: A Semistructured Interview Study. Journal of Pain and Symptom Management, 51(4), 706-717.e5. [More Information]
• Ibiebele, I., Coory, M., Smith, G., Boyle, F., Vlack, S., Middleton, P., Roe, Y., Flenady, V. (2016). Gestational age specific stillbirth risk among Indigenous and non-Indigenous women in Queensland, Australia: A population based study. BMC Pregnancy and Childbirth, 16(1). [More Information]
• Strasser-Weippl, K., Horick, N., Smith, I., O'Shaughnessy, J., Ejlertsen, B., Boyle, F., Buzdar, A., Fumoleau, P., Gradishar, W., et al (2016). Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. European Journal of Cancer, 56, 85-92. [More Information]
• Sonnenblick, A., de Azambuja, E., Agbor-tarh, D., Bradbury, I., Campbell, C., Huang, Y., Dueck, A., Pritchard, K., Boyle, F., et al (2016). Lapatinib-related rash and breast cancer outcome in the ALTTO phase III randomized trial. Journal of the National Cancer Institute, 108(8), 1-8. [More Information]
• Kinner, S., Alati, R., Longo, M., Spittal, M., Boyle, F., Williams, G., Lennox, N. (2016). Low-intensity case management increases contact with primary care in recently released prisoners: A single-blinded, multisite, randomised controlled trial. Journal of Epidemiology and Community Health, 70(7), 683-688. [More Information]
• Zdenkowski, N., Forbes, J., Boyle, F., Kannourakis, G., Gill, P., Bayliss, E., Saunders, C., Della-Fiorentina, S., Kling, N., Coates, A., Gebski, V., Davies, L., et al (2016). Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trial. Annals of Oncology, 27(5), 806-812. [More Information]
• Brennan, M., Butow, P., Spillane, A., Boyle, F. (2016). Patient-reported quality of life, unmet needs and care coordination outcomes: Moving toward targeted breast cancer survivorship care planning. Asia-Pacific Journal of Clinical Oncology, 12(2), e323-e331. [More Information]
• Dong, S., Butow, P., Jaure, A., Agar, M., Boyle, F., Forster, B., Stockler, M., Lovell, M. (2016). Patients' experiences and perspectives of multiple concurrent symptoms in advanced cancer: a semi-structured interview study. Supportive Care in Cancer, 24(3), 1373-1386. [More Information]
• Shaw, J., Baylock, B., O'Reilly, A., Winstanley, J., Pugliano, L., Andrews, K., Boyle, F. (2016). Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer. Supportive Care in Cancer, 24(9), 3813-3820. [More Information]
• Flenady, V., Wojcieszek, A., Middleton, P., Ellwood, D., Erwich, J., Coory, M., Khong, T., Silver, R., Smith, G., Boyle, F., et al (2016). Stillbirths: Recall to action in high-income countries. The Lancet, 387(10019), 691-702. [More Information]
• Zdenkowsk, N., Tesson, S., Lombard, J., Lovell, M., Hayes, S., Francis, P., Dhillon, H., Boyle, F. (2016). Supportive care of women with breast cancer: key concerns and practical solutions. Medical Journal of Australia, 205(10), 471-475. [More Information]
• Boyle, F., Dean, J., Young, C., Mutch, A. (2016). Why do people with chronic disease not contact consumer health organisations? A survey of general practice patients. Primary Health Care Research and Development, 17(4), 393-404. [More Information]

2015

• Chung, L., Phillips, L., Lin, Z., Moore, K., Marsh, D., Boyle, F., Baxter, R. (2015). A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancer. Cancer Letters, 368(1), 64-70. [More Information]
• Bae, K., Yoo, H., Lamoury, G., Boyle, F., Rosenthal, D., Oh, B. (2015). Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review. Integrative Cancer Therapies, 14(6), 496-502. [More Information]
• Lovell, M., Luckett, T., Boyle, F., Stubbs, J., Phillips, J., Davidson, P., Oliver, I., von Dincklage, J., Agar, M. (2015). Adaptation of international guidelines on assessment and management of cancer pain for the Australian context. Asia-Pacific Journal of Clinical Oncology, 11(2), 170-177. [More Information]
• Butow, P., Brown, R., Aldridge, J., Juraskova, I., Zoller, P., Boyle, F., Wilson, M., Bernhard, J. (2015). Can consultation skills training change doctors' behaviour to increase involvement of patients in making decisions about standard treatment and clinical trials: a randomized controlled trial. Health Expectations, 18(6), 2570-2583. [More Information]
• Winstanley, J., Young, T., Boyle, F., Bergenmar, M., Bottomley, A., Burmeister, B., Campana, L., Garioch, J., King, M., Nikolic, D., Saw, R., Thompson, J., et al (2015). Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module. Melanoma Research, 25, 47-58. [More Information]
• Zdenkowski, N., Butow, P., Mann, B., Fewster, S., Douglas, C., Boyle, F. (2015). Decisions about neoadjuvant systemic therapy for breast cancer: a survey of Australian and New Zealand specialists. ANZ Journal of Surgery, 85(11), 797-799. [More Information]
• Inglis, H., Boyle, F., Friedlander, M., Watson, S. (2015). Dry eyes and AIs: If you don't ask you won't find out. The Breast, 24(6), 694-698. [More Information]
• Brennan, M., Boyle, F., Butow, P., Spillane, A. (2015). Evaluation of a survivorship care plan: long-term use, care coordination and quality of life in breast cancer survivors. Breast Cancer Management, 4(3), 145-157. [More Information]
• Dickfos, M., King, D., Parekh, S., Boyle, F., Vandelanotte, C. (2015). General practitioners' perceptions of and involvement in health behaviour change: can computer-tailored interventions help? Primary Health Care Research and Development, 16(3), 316-321. [More Information]
• Moore, H., Unger, J., Phillips, K., Boyle, F., Hitre, E., Porter, D., Francis, P., Goldstein, L., Gomez, H., Vallejos, C., et al (2015). Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. New England Journal of Medicine, 372(10), 923-932. [More Information]
• Moore, H., Unger, J., Phillips, K., Boyle, F., Hitre, E., Porter, D., Francis, P., Goldstein, L., Gomez, H., Vallejos, C., et al (2015). Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. Obstetrical and Gynecological Survey, 70(6), 392-393. [More Information]
• Lui, C., Coll, J., Donald, M., Dower, J., Boyle, F. (2015). Health and social correlates of Internet use for diabetes information: Findings from Australia's Living with Diabetes Study. Australian Journal of Primary Health, 21(3), 327-333. [More Information]
• Boyle, F., Smith, I., O’Shaughnessy, J., Ejlertsen, B., Buzdar, A., Fumoleau, P., Gradishar, W., Martin, M., Moy, B., Piccart-Gebhart, M., et al (2015). Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. European Journal of Cancer, 51(6), 685-696. [More Information]
• Eakin, E., Hayes, S., Haas, M., Reeves, M., Vardy, J., Boyle, F., Hiller, J., Mishra, G., Goode, A., Jefford, M., White, K., et al (2015). Healthy Living after Cancer: a dissemination and implementation study evaluating a telephone-delivered healthy lifestyle program for cancer survivors. BMC Cancer, 15(1), 1-11. [More Information]
• Wilson, P., Boyle, F., Ware, R. (2015). Holding a stillborn baby: The view from a specialist perinatal bereavement service. Australian and New Zealand Journal of Obstetrics and Gynaecology, 55(4), 337-343. [More Information]
• Quinton, T., Lazzarini, P., Boyle, F., Russell, A., Armstrong, D. (2015). How do Australian podiatrists manage patients with diabetes? The Australian diabetic foot management survey. Journal of Foot and Ankle Research, 8(1). [More Information]
• Gelmon, K., Boyle, F., Kaufman, B., Huntsman, D., Manikhas, A., Di Leo, A., Martin, M., Schwartzberg, L., Lemieux, J., et al (2015). Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31. Journal of Clinical Oncology, 33(14), 1574-1583. [More Information]
• Strasser-Weippl, K., Horick, N., Smith, I., O’Shaughnessy, J., Ejlertsen, B., Boyle, F., Buzdar, A., Fumoleau, P., Gradishar, W., Martin, M., et al (2015). Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. Breast Cancer Research, 17(1), 1-7. [More Information]
• van den Hurk, C., Winstanley, J., Young, A., Boyle, F. (2015). Measurement of chemotherapy-induced alopecia-time to change. Supportive Care in Cancer, 23(5), 1197-1199. [More Information]
• Gedye, C., Boyle, F. (2015). Optimising treatment for Australian melanoma patients can save taxpayers millions of dollars annually. Medical Journal of Australia, 202(3), 130-130. [More Information]
• Ibiebele, I., Coory, M., Boyle, F., Humphrey, M., Vlack, S., Flenady, V. (2015). Stillbirth rates among Indigenous and non-Indigenous women in Queensland, Australia: is the gap closing? BJOG, 122(11), 1476-1483. [More Information]
• Boyle, F., Mutch, A., Barber, E., Carroll, C., Dean, J. (2015). Supporting parents following pregnancy loss: A cross-sectional study of telephone peer supporters. BMC Pregnancy and Childbirth, 15(1). [More Information]
• Brown, N., Lui, C., Robinson, P., Boyle, F. (2015). Supportive care needs and preferences of lung cancer patients: a semi-structured qualitative interview study. Supportive Care in Cancer, 23(6), 1533-1539. [More Information]
• Read, R., Flitcroft, K., Snook, K., Boyle, F., Spillane, A. (2015). Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer. ANZ Journal of Surgery, 85(5), 315-320. [More Information]

2014

• Tan, J., Butow, P., Boyle, F., Saw, R., O'Reilly, A. (2014). A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers. Melanoma Research, 24(3), 252-260. [More Information]
• Luckett, T., Davidson, P., Boyle, F., Winston, L., Agar, M., Green, A., Lovell, M. (2014). Australian survey of current practice and guideline use in adult cancer pain assessment and management: Perspectives of oncologists. Asia-Pacific Journal of Clinical Oncology, 10(2), e99-e107. [More Information]
• Bowen, J., Mayo, B., Plews, E., Bateman, E., Wignall, A., Stringer, A., Boyle, F., Keefe, D. (2014). Determining the mechanisms of lapatinib-induced diarrhoea using a rat model. Cancer Chemotherapy and Pharmacology, 74(3), 617-627. [More Information]
• Kemp, A., Preen, D., Saunders, C., Boyle, F., Bulsara, M., Malacova, E., Roughead, E. (2014). Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice? SpringerPlus, 3(1), 1-10. [More Information]
• Oh, B., Butow, P., Boyle, F., Beale, P., Costa, D., Pavlakis, N., Bell, D., Davis, E., Choi, S., Lee, M., Clarke, S., et al (2014). Effects of Qigong on Quality of Life, Fatigue, Stress, Neuropathy, and Sexual Function in Women with Metastatic Breast Cancer: A Feasibility Study. International Journal of Physical Medicine & Rehabilitation, 2(4), 1-6. [More Information]
• Juraskova, I., Butow, P., Bonner, C., Bell, M., Smith, B., Seccombe, M., Boyle, F., Reaby, L., Cuzick, J., Forbes, J. (2014). Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial. British Journal of Cancer, 111(1), 1-17. [More Information]
• De Azambuja, E., Holmes, A., Piccart-Gebhart, M., Holmes, E., Di Cosimo, S., Swaby, R., Untch, M., Jackisch, C., Lang, I., Smith, I., Boyle, F., et al (2014). Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response. The Lancet Oncology, 15(10), 1137-1146. [More Information]
• Flenady, V., Boyle, F., Koopmans, L., Wilson, T., Stones, W., Cacciatore, J. (2014). Meeting the needs of parents after a stillbirth or neonatal death. BJOG, 121, 137-140. [More Information]
• McCarthy, N., Boyle, F., Zdenkowski, N., Bull, J., Leong, E., Simpson, A., Kannourakis, G., Francis, P., Chirgwin, J., Abdi, E., Gebski, V., Wilcken, N., et al (2014). Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem). Breast, 23(2), 142-151. [More Information]
• Chung, L., Katrina, M., Phillips, L., Boyle, F., Marsh, D., Baxter, R. (2014). Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer. Breast Cancer Research, 16(3), 1-12. [More Information]
• Lovell, M., Luckett, T., Boyle, F., Phillips, J., Agar, M., Davidson, P. (2014). Patient Education, Coaching, and Self-Management for Cancer Pain. Journal of Clinical Oncology, 32(16), 1712-1720. [More Information]
• Gormally, J., Izard, M., Robinson, B., Boyle, F. (2014). Pituitary metastasis from breast cancer presenting as diabetes insipidus. BMJ Case Reports, 2014, 1-4. [More Information]
• Parekh, S., King, D., Boyle, F., Vandelanotte, C. (2014). Randomized controlled trial of a computer-tailored multiple health behaviour intervention in general practice: 12-month follow-up results. International Journal of Behavioral Nutrition and Physical Activity, 11(1). [More Information]
• Brennan, M., Gormally, J., Butow, P., Boyle, F., Spillane, A. (2014). Survivorship care plans in cancer: a systematic review of care plan outcomes. British Journal of Cancer, 111(10), 1899-1908. [More Information]
• Kemp, A., Preen, D., Saunders, C., Boyle, F., Bulsara, M., Holman, D., Malacova, E., Roughead, E. (2014). Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice. PloS One, 9(1), 1-8. [More Information]

2013

• Goss, P., Smith, I., O'Shaughnessy, J., Ejlertsen, B., Kaufmann, M., Boyle, F., Buzdar, A., Fumoleau, P., Gradishar, W., Martin, M., et al (2013). Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial. The Lancet Oncology, 14(1), 88-96. [More Information]
• Metzger-Filho, O., de Azambuja, E., Bradbury, I., Saini, K., Bines, J., Simon, S., van Dooren, V., Aktan, G., Pritchard, K., Wolff, A., et al (2013). Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: The adjuvant lapatinib and/or trastuzumab treatment optimization experience. The Oncologist, 18(2), 134-140. [More Information]
• Luckett, T., Davidson, P., Green, A., Boyle, F., Stubbs, J., Lovell, M. (2013). Assessment and Management of Adult Cancer Pain: A Systematic Review and Synthesis of Recent Qualitative Studies Aimed at Developing Insights for Managing Barriers and Optimizing Facilitators Within a Comprehensive Framework of Patient Care. Journal of Pain and Symptom Management, 46(2), 229-253. [More Information]
• Milne, T., Rogers, J., Kinnear, E., Martin, H., Lazzarini, P., Quinton, T., Boyle, F. (2013). Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: A systematic review. Journal of Foot and Ankle Research, 6(1). [More Information]
• Clayton, J., Butow, P., Waters, A., Laidsaar-Powell, R., O'Brien, A., Boyle, F., Back, A., Arnold, R., Tulsky, J., Tattersall, M. (2013). Evaluation of a novel individualised communication-skills training intervention to improve doctors' confidence and skills in end-of-life communication. Palliative Medicine, 27(3), 236-243. [More Information]
• Lennox, N., Brolan, C., Dean, J., Ware, R., Boyle, F., Taylor Gomez, M., van Dooren, K., Bain, C. (2013). General practitioners' views on perceived and actual gains, benefits and barriers associated with the implementation of an Australian health assessment for people with intellectual disability. Journal of Intellectual Disability Research, 57(10), 913-922. [More Information]
• Eagleson, K., Justo, R., Ware, R., Johnson, S., Boyle, F. (2013). Health-related quality of life and congenital heart disease in Australia. Journal of Paediatrics and Child Health, 49(10), 856-864. [More Information]
• Cusack, L., Brennan, M., Baber, R., Boyle, F. (2013). Menopausal symptoms in breast cancer survivors: management update. British Journal of General Practice, 63(606), 51-52. [More Information]
• Lovell, M., Boyle, F. (2013). Overcoming cancer pain: a guide for people with cancer, their families and friends. Australia: Cancer Council Australia.
• Thewes, B., Bell, M., Butow, P., Beith, J., Boyle, F., Friedlander, M., McLachlan, S. (2013). Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study. Psycho-Oncology, 22(12), 2797-2806. [More Information]
• Lee, N., Lucke, J., Hall, W., Meurk, C., Boyle, F., Carter, A. (2013). Public Views on Food Addiction and Obesity: Implications for Policy and Treatment. PloS One, 8(9). [More Information]
• Kinner, S., Lennox, N., Williams, G., Carroll, M., Quinn, B., Boyle, F., Alati, R. (2013). Randomised controlled trial of a service brokerage intervention for ex-prisoners in australia. Contemporary Clinical Trials, 36(1), 198-206. [More Information]
• Stein, R., Sharpe, L., Bell, M., Boyle, F., Dunn, S., Clarke, S. (2013). Randomized Controlled Trial of a Structured Intervention to Facilitate End-of-Life Decision Making in Patients With Advanced Cancer. Journal of Clinical Oncology, 31(27), 3403-3410. [More Information]
• Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al (2013). Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling, 92(2), 246-252. [More Information]
• Winstanley, J., Saw, R., Boyle, F., Thompson, J. (2013). The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model. Melanoma Research, 23(1), 61-69. [More Information]
• Chung, L., Shibli, S., Moore, K., Elder, E., Boyle, F., Marsh, D., Baxter, R. (2013). Tissue biomarkers of breast cancer and their association with conventional pathologic features. British Journal of Cancer, 108(2), 351-360. [More Information]
• Hillen, M., Butow, P., Tattersall, M., Hruby, G., Boyle, F., Vardy, J., Kallimanis-King, B., de Haes, H., Smets, E. (2013). Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Education and Counseling, 91(1), 25-28. [More Information]
• Winstanley, J., White, E., Boyle, F., Thompson, J. (2013). What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Melanoma Research, 23(2), 167-174. [More Information]

2012

• Goldstein, D., Bennett, B., Webber, K., Boyle, F., De Souza, P., Wilcken, N., Scott, E., Toppler, R., Murie, P., O'Malley, L., Hickie, I., et al (2012). Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study. Journal of Clinical Oncology, 30(15), 1805-1812. [More Information]
• Bowen, J., Mayo, B., Plews, E., Bateman, E., Stringer, A., Boyle, F., Finnie, J., Keefe, D. (2012). Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea. Cancer Biology & Therapy, 13(13), 1269-1275. [More Information]
• Cameron, B., Bennett, B., Li, H., Boyle, F., deSouza, P., Wilcken, N., Friedlander, M., Goldstein, D., Lloyd, A. (2012). Post-cancer fatigue is not associated with immune activation or altered cytokine production. Annals of Oncology, 23(11), 2890-2895. [More Information]
• Sung-In Jang, H., Spillane, A., Boyle, F., Fogarty, G. (2012). Radiotherapy can cause haemostasis in bleeding skin malignancies. Case Reports in Medicine, 2012 (0), 168681- 1-168681- 4. [More Information]

2011

• Lee, C., Hudson, M., Stockler, M., Coates, A., Ackland, S., Gebski, V., Lord, S., Friedlander, M., Boyle, F., Simes, R. (2011). A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer. Breast Cancer Research and Treatment, 129(2), 467-476. [More Information]
• Tolerton, S., Shaw, J., O'Reilly, A., Dunn, S., Boyle, F. (2011). Exploring consent to randomized placebo-controlled clinical trials in oncology. Asia-Pacific Journal of Clinical Oncology, 7(3), 300-306. [More Information]
• Brennan, M., Butow, P., Spillane, A., Marven, M., Boyle, F. (2011). Follow up after breast cancer - views of Australian women. Australian Family Physician, 40(5), 311-316. [More Information]
• Brennan, M., Butow, P., Marven, M., Spillane, A., Boyle, F. (2011). Survivorship care after breast cancer treatment - Experiences and preferences of Australian women. Breast, 20(3), 271-277. [More Information]

2010

• Lovell, M., Forder, P., Stockler, M., Butow, P., Briganti, E., Chye, R., Goldstein, D., Boyle, F. (2010). A Randomized Controlled Trial of a Standardized Educational Intervention for Patients with Cancer Pain. Journal of Pain and Symptom Management, 40(1), 49-59. [More Information]
• Blyth, F., Boyle, F. (2010). Cancer and chronic pain. In Peter Croft, Fiona Blyth, Danielle van der Windt (Eds.), Chronic Pain Epidemiology: From Aetiology to Public Health, (pp. 271-276). Oxford: Oxford University Press. [More Information]
• Lovell, M., Boyle, F. (2010). Cancer Pain Management. Medicine Today, 11(1), 33-38.
• Kaser, E., Shaw, J., Marven, M., Swinburn, L., Boyle, F. (2010). Communication about high-cost drugs in oncology-the patient view. Annals of Oncology, 21(9), 1910-1914. [More Information]
• Lovell, M., Boyle, F. (2010). Communication strategies and skills for optimal pain control. In David Kissane, Barry Bultz, Phyllis Butow, Ilora Finlay (Eds.), Handbook Of Communication In Oncology And Palliative Care, (pp. 315-326). Oxford: Oxford University Press. [More Information]
• Schapira, L., Butow, P., Brown, R., Boyle, F. (2010). Pessimism Is No Poison. Journal of Clinical Oncology, 28(4), 705-707. [More Information]
• Brennan, M., Butow, P., Spillane, A., Boyle, F. (2010). Survivorship care after breast cancer: Follow-up practices of Australian health professionals and attitudes to a survivorship care plan. Asia-Pacific Journal of Clinical Oncology, 6(2), 116-125. [More Information]

2009

• Snyder, R., Boyle, F., Chan, A., Craft, P., de Boer, R., Mainwaring, P., McCarthy, N., Wilcken, N. (2009). Clinical recommendations for the use of lapatinib ditosylate plus capecitabine for patients with advanced or metastatic HER2-positive breast cancer. Asia-Pacific Journal of Clinical Oncology, 5(1), 4-16. [More Information]
• Boyle, F. (2009). Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice. Cancer Treatment and Research, 151, 93-101. [More Information]

2008

• Duric, V., Butow, P., Sharpe, L., Heritier, S., Boyle, F., Beith, J., Wilcken, N., Coates, A., Simes, R., Stockler, M. (2008). Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer. Patient Education and Counseling, 72(2), 239-245. [More Information]
• Juraskova, I., Butow, P., Lopez, A., Seccombe, M., Coates, A., Boyle, F., McCarthy, N., Reaby, L., Forbes, J. (2008). Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expectations, 11(3), 252-262. [More Information]
• Crown, J., Burris III, H., Boyle, F., Jones, S., Koehler, M., Newstat, B., Parikh, R., Oliva, C., Preston, A., Byrne, J., et al (2008). Pooled analysis of diarrhea events in patients with cancer treated with lapatinib. Breast Cancer Research and Treatment, 112(2), 317-325. [More Information]

2007

• Butow, P., Tattersall, M., Boyle, F., Introna, K., Kearsley, J., Kristjanson, L., Martin, P., Meller, A., Mitchell, G., Moore, A., Olver, I., et al (2007). Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Medical Journal of Australia, 186(12), S77-S79. [More Information]
• Murphy, S., Boyle, F., Davey, R., Gu, X., Mather, L. (2007). Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. Journal of Pharmacy and Pharmacology, 59(1), 105-114. [More Information]
• Murphy, S., Davey, R., Gu, X., Haywood, M., McCann, L., Mather, L., Boyle, F. (2007). Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model. Journal of Neuro-Oncology, 85(2), 181-189. [More Information]
• Juraskova, I., Butow, P., Lopez, A., Seccombe, M., Boyle, F., McCarthy, N., Forbes, J. (2007). Improving informed consent to clinical trials: Successful piloting of a decision aid. Journal of Clinical Oncology, 25(11), 1443-1444. [More Information]
• Duric, V., Butow, P., Sharpe, L., Boyle, F., Beith, J., Wilcken, N., Heritier, S., Coates, A., Simes, R., Stockler, M. (2007). Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psycho-Oncology, 16(1), 48-59. [More Information]

2006

• Dalton, L., Luxford, K., Boyle, F., Goldstein, D., Underhill, C., Yates, P. (2006). An educational workshop program for rural practitioners to encourage best practice for delivery of systemic adjuvant therapy. Journal of Cancer Education, 21(1), 35-39. [More Information]
• Brown, R., Butow, P., Boyle, F., Tattersall, M. (2006). Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training. Psycho-Oncology, 16(6), 507-516. [More Information]
• Murphy, S., Boyle, F., Gu, X., Mather, L. (2006). Thalidomide enantiomers: determination in biological samples by HPLC and vancomycin-CSP. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 831, 48-56. [More Information]

2005

• Duric, V., Stockler, M., Butow, P., Sharpe, L., Heritier, S., Beith, J., Boyle, F., Wilcken, N., Coates, A., Simes, R. (2005). Comparing patients' and their partners' preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC). Journal of Clinical Oncology, 23(16S), 546S-546S.
• Boyle, F., Robinson, E., Dunn, S., Heinrich, P. (2005). Multidisciplinary Care in Cancer: The Fellowship of the Ring. Journal of Clinical Oncology, 23(4), 916-920. [More Information]
• Duric, V., Stockler, M., Heritier, S., Boyle, F., Beith, J., Sullivan, A., Wilcken, N., Coates, A., Simes, R. (2005). Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? Annals of Oncology, 16(11), 1786-1794. [More Information]
• Thewes, B., Meiser, B., Duric, V., Stockler, M., Taylor, A., Stuart-Harris, R., Links, M., Wilcken, N., McLachlan, S., Phillips, K., Boyle, F., et al (2005). What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? The Lancet Oncology, 6(8), 581-588. [More Information]

2004

• Boyle, F., Dunn, S., Robinson, E., Heinrich, P. (2004). Cancer: Communicating In The Team Game. ANZ Journal of Surgery, 74(6), 477-481. [More Information]
• Brown, R., Butow, P., Sharrock, M., Henman, M., Boyle, F., Goldstein, D., Tattersall, M. (2004). Education And Role Modelling For Clinical Decisions With Female Cancer Patients. Health Expectations, 7(4), 303-316. [More Information]
• Boyle, F., Scott, C., Ferrier, A., Baron-Hay, S. (2004). Elevated Serum Insulin-Like Growth Factor Binding Protein-2 As A Prognostic Marker In Patients With Ovarian Cancer. Clinical Cancer Research, 10(5), 1796-1806. [More Information]
• Boyle, F., Eller, S., Grossman, S. (2004). Penetration Of Intra-Arterially Administered Vincristine In Experimental Brain Tumor. Neuro-Oncology, 6(4), 300-305. [More Information]
• Duric, V., Stockler, M., Butow, P., Sharpe, L., Beith, J., Sullivan, A., Boyle, F., Dhillon, H., Coates, A., Simes, R. (2004). Predictors of the benefits women consider necessary to make adjuvant chemotherapy (ACT) worthwhile for early breast cancer (EBC). Journal of Clinical Oncology, 22(14S), 73S-73S.
• Brown, R., Butow, P., Ellis, P., Boyle, F., Tattersall, M. (2004). Seeking Informed Consent To Cancer Clinical Trials: Describing Current Practice. Social Science and Medicine, 58(12), 2445-2457. [More Information]

2003

• Baber, R., O'Hara, J., Boyle, F. (2003). Hormone replacement therapy: to use or not to use? Medical Journal of Australia, 178(12), 630-633.
• Boyle, F., Dunn, S., Riches, J. (2003). More than one way to foster communication skills for medical oncology fellows: a national program in Australia. Journal of Clinical Oncology, 11. [More Information]
• Potter, V., Wiseman, C., Dunn, S., Boyle, F. (2003). Patient barriers to optimal cancer pain control. Psycho-Oncology, 12(2), 153-160. [More Information]

2002

• Loh, W., Butow, P., Brown, R., Boyle, F. (2002). Ethical Communication in Clinical Trials: Issues Faced by Data Manager in Obtaining Informed Consent. Cancer, 95(11), 2414-2421. [More Information]
• Henman, M., Butow, P., Brown, R., Boyle, F., Tattersall, M. (2002). Lay constructions of decision-making in cancer. Psycho-Oncology, 11(4), 295-306. [More Information]
• Brown, R., Butow, P., Henman, M., Dunn, S., Boyle, F., Tattersall, M. (2002). Responding to the active and passive patient: flexibility is the key. Health Expectations, 5(3), 236-245. [More Information]